<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00429208</url>
  </required_header>
  <id_info>
    <org_study_id>yakir@hmo</org_study_id>
    <nct_id>NCT00429208</nct_id>
  </id_info>
  <brief_title>Effect Of Nicotine on Neurocognitive Performance of Cigarette Smokers</brief_title>
  <official_title>Effect Of Nicotine on Neurocognitive Performance of Cigarette Smokers: A Double-Blind, Within-Subjects, Placebo-Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hadassah Medical Organization</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hadassah Medical Organization</source>
  <brief_summary>
    <textblock>
      This research project addresses the hypothesis that a neurocognitive profile characterized by
      impairment of response inhibition and sustained attention may be a risk factor for smoking
      initiation and nicotine dependence among young women. Nicotine has short- term, facilitating
      effects on attention and response inhibition. Therefore, individuals who are impaired on
      cognitive functions such as these and initiate cigarette smoking may be more likely to
      maintain the habit and develop nicotine dependence. The research protocol specifically tests
      whether administration of nicotine to non-abstinent, regular cigarette smokers improves
      cognitive function in those domains where the participants had previously been shown to
      manifest performance deficits
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>February 2007</start_date>
  <completion_date type="Anticipated">April 2007</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Neurocognitive functions</measure>
  </primary_outcome>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Nicotine Dependence</condition>
  <condition>Smoking</condition>
  <condition>Tobacco Use Disorder</condition>
  <condition>Nicotine Use Disorder</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nicotine</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Reported smoking cigarettes on a daily basis at the time of the original study and
             continue to smoke currently

          -  Manifested poor performance on the MFFT (The neurocognitive test that yielded
             differences between smokers and non-smokers)

          -  Competent and willing to give written informed consent

        Exclusion Criteria:

          -  Pregnancy, breast-feeding, non-use of contraception such that the possibility of
             pregnancy cannot be excluded

          -  Intake of any medication that may potentially interact with nicotine.

          -  Any current or past medical condition that represents a contra-indication to nicotine
             administration.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Avi Yakir, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hadassah Medical Organization</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Avi Yakir, MD</last_name>
    <phone>00 972 2 6777184</phone>
    <email>yakir@hadassah.org.il</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hadas Lemberg, PhD</last_name>
    <phone>00 972 2 6777572</phone>
    <email>lhadas@hadassah.org.il</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hadassah Medical Organization</name>
      <address>
        <city>Jerusalem</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Arik Tzukert, DMD</last_name>
      <phone>00 972 2 6776095</phone>
      <email>arik@hadassah.org.il</email>
    </contact>
    <contact_backup>
      <last_name>Hadas Lemberg, PhD</last_name>
      <phone>00 972 2 6777572</phone>
      <email>lhadas@hadassah.org.il</email>
    </contact_backup>
    <investigator>
      <last_name>Avi Yakir, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <link>
    <url>http://www.hadassah.org.il/Hadassa/Heb_SubNavBar/Departments/Medical+departments/Psychiatry/BioPsychiatry/</url>
    <description>Biological Psychiatry Laboratory Hadassah- Hebrew University Medical Center, Jerusalem, Israel</description>
  </link>
  <results_reference>
    <citation>Yakir A, Rigbi A, Kanyas K, Pollak Y, Kahana G, Karni O, Eitan R, Kertzman S, Lerer B. Why do young women smoke? III. Attention and impulsivity as neurocognitive predisposing factors. Eur Neuropsychopharmacol. 2007 Apr;17(5):339-51. Epub 2006 Nov 30.</citation>
    <PMID>17141485</PMID>
  </results_reference>
  <verification_date>January 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 30, 2007</study_first_submitted>
  <study_first_submitted_qc>January 30, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 31, 2007</study_first_posted>
  <last_update_submitted>January 30, 2007</last_update_submitted>
  <last_update_submitted_qc>January 30, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 31, 2007</last_update_posted>
  <keyword>Nicotine Dependence</keyword>
  <keyword>Smoking</keyword>
  <keyword>Tobacco Use Disorder</keyword>
  <keyword>Nicotine Use Disorder</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Tobacco Use Disorder</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nicotine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

